Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 2,373 | 4,678 | 4,853 | 3,397 | 6,241 |
| Operating Income | -2,373 | -4,678 | -4,853 | -3,397 | -6,241 |
| Interest Expense | -73 | 92 | 117 | 22 | 2 |
| Other Income | -1,402 | 22 | -4,796 | -5,320 | 787 |
| Pre-tax Income | -3,703 | -4,748 | -9,766 | -8,740 | -5,456 |
| Net Income Continuous | -3,703 | -4,748 | -9,766 | -8,740 | -5,456 |
| Minority Interests | -840 | 571 | -513 | N/A | -284 |
| Net Income | $-2,863 | $-5,319 | $-9,253 | $-8,740 | $-5,172 |
| EPS Basic Total Ops | -0.19 | -1.25 | -3.23 | -3.53 | -5.24 |
| EPS Basic Continuous Ops | -0.19 | -1.25 | -3.23 | -3.53 | -5.24 |
| EPS Diluted Total Ops | -0.19 | -1.25 | -3.23 | -3.53 | -5.24 |
| EPS Diluted Continuous Ops | -0.19 | -1.25 | -3.23 | -3.53 | -5.24 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -1.25 | -3.23 | -1.41 | -2.89 |
| EBITDA(a) | $-2,244 | $-4,533 | $-4,712 | $-3,268 | $-6,128 |